Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma

BACKGROUND: Cholangiocellular cancers account for about 10-15% of primary liver cancers. Prognosis is poor, with expected survival of less than 5% at five-year. CASE PRESENTATION: The case described shows remission of a disseminated cholangiocellular carcinoma (focal changes in liver, metastases to...

Descripción completa

Detalles Bibliográficos
Autores principales: Slupski, Maciej W, Szczylik, Cezary, Jasinski, Milosz K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Technical Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839091/
https://www.ncbi.nlm.nih.gov/pubmed/17376238
http://dx.doi.org/10.1186/1477-7819-5-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839091/
https://www.ncbi.nlm.nih.gov/pubmed/17376238
http://dx.doi.org/10.1186/1477-7819-5-36

Ejemplares similares